Education
About Us
Working with TipRanks
Follow Us
Biocryst Pharmaceuticals (BCRX)
NASDAQ:BCRX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 450.71M | $ 331.41M | $ 270.83M | $ 157.17M | $ 17.81M |
| Gross Profit | $ 438.44M | $ 326.75M | $ 264.23M | $ 149.91M | $ 16.14M |
| Operating Income | $ -2.54M | $ -103.71M | $ -148.44M | $ -177.72M | $ -174.76M |
| EBITDA | $ 12.81M | $ -116.33M | $ -143.85M | $ -121.74M | $ -167.56M |
| Net Income | $ -88.88M | $ -226.54M | $ -247.12M | $ -184.06M | $ -196.57M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 320.85M | $ 388.99M | $ 442.39M | $ 514.43M | $ 300.37M |
| Total Assets | $ 490.42M | $ 516.96M | $ 550.00M | $ 588.15M | $ 334.71M |
| Total Debt | $ 12.82M | $ 848.71M | $ 741.45M | $ 593.24M | $ 124.72M |
| Net Debt | $ -91.89M | $ 714.50M | $ 436.69M | $ 88.85M | $ -147.41M |
| Total Liabilities | $ 966.35M | $ 972.49M | $ 844.60M | $ 695.14M | $ 353.98M |
| Stockholders' Equity | $ -475.93M | $ -455.53M | $ -1.45B | $ -1.21B | $ -1.02B |
| Cash Flow | |||||
| Free Cash Flow | $ -52.02M | $ -97.31M | $ -163.20M | $ -144.54M | $ -137.73M |
| Operating Cash Flow | $ -52.02M | $ -95.14M | $ -161.85M | $ -142.16M | $ -137.22M |
| Investing Cash Flow | $ 52.59M | $ -131.50M | $ -128.24M | $ 15.80M | $ -6.86M |
| Financing Cash Flow | $ -5.76M | $ 32.48M | $ 88.03M | $ 359.67M | $ 302.70M |